These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6450060)

  • 61. Some derivatives of arecaidine.
    Dolby J; Dahlbom R
    Acta Pharm Suec; 1969 Apr; 6(2):271-6. PubMed ID: 5824841
    [No Abstract]   [Full Text] [Related]  

  • 62. [Adamantoates of cardanolides].
    Just H; Baumgarten G; Reissbrodt R
    Pharmazie; 1973 May; 28(5):336-7. PubMed ID: 4715053
    [No Abstract]   [Full Text] [Related]  

  • 63. The methylation of nicotine with methyl-lithium.
    Haglid F
    Acta Chem Scand; 1967; 21(2):329-34. PubMed ID: 6048663
    [No Abstract]   [Full Text] [Related]  

  • 64. [Heterosubstituted fulvenes. V. 6,6-diaminofulvenes with electronegative substituents in the 5-membered ring].
    Hartke K; Salamon G
    Chem Ber; 1970; 103(1):147-55. PubMed ID: 5410743
    [No Abstract]   [Full Text] [Related]  

  • 65. Pseudonucleoside analogs. Synthesis and spectral properties of 5-(cis-3-hydroxymethylcyclopentane)uracil, a carbocyclic analog of 2',3'-dideoxypseudouridine.
    Playtis AJ; Fissekis JD
    J Org Chem; 1975 Aug; 40(17):2488-95. PubMed ID: 1165510
    [No Abstract]   [Full Text] [Related]  

  • 66. Structural requirements for pyrethrin-like activity.
    Elliott M
    Chem Ind; 1969 Jun; 24():776-81. PubMed ID: 5783495
    [No Abstract]   [Full Text] [Related]  

  • 67. [The anticoagulant 2,5-diarylcyclopent-4-ene-1,3-dione].
    Rehse K; Lehmke J
    Arch Pharm (Weinheim); 1984 Aug; 317(8):714-7. PubMed ID: 6497600
    [No Abstract]   [Full Text] [Related]  

  • 68. [The anticoagulant arylalkyl- arylalkyidene-cyclopent-4-ene-1,3-diones].
    Rehse K; Lehmke J
    Arch Pharm (Weinheim); 1984 Sep; 317(9):781-9. PubMed ID: 6508511
    [No Abstract]   [Full Text] [Related]  

  • 69. Molecular requirements of the active sites of the cholinergic receptors. XI - Synthesis and biological evaluation of isomuscarie and its isomers.
    Pigini M; Ballini R; Gualtieri F; Brasili L
    Farmaco Sci; 1980 Mar; 35(3):167-80. PubMed ID: 6450059
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular requirements of the active sites of the cholinergic receptors. XIII - Stereospecific synthesis of 3c-methyl-2t-hydroxy-lr-dimethyl-aminomethylcyclopentane methiodide and its dehydroderivative.
    Giannella M; Leonelli M; Pigini M
    Farmaco Sci; 1980 Apr; 35(4):263-8. PubMed ID: 6450061
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular requirements of the active sites of the cholinergic receptors. XVI - Synthesis and cholinergic activity of 2- or 5-alkyl or 5-phenyl-4-methyl-3-oxo-1-dimethylaminomethylcyclopentane methiodide.
    Pigini M; Brasili L
    Farmaco Sci; 1981 Feb; 36(2):152-8. PubMed ID: 7227502
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cholinergic compounds. II - Synthesis and biological activity of epi- and allo-desethermuscarines.
    Gualtieri F; Gianella M; Melchiorre C; Pigini M
    Farmaco Sci; 1975 Mar; 30(3):223-37. PubMed ID: 1116599
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular requirements of the active sites of the cholinergic receptors. XII - 3-Methyl-2-oxo-1-dimethylaminomethylcyclopentane methiodide as a new selective agonist for the nicotinic receptor.
    Giannella M; Angeli P; Melchiorre C; Brasili L
    Farmaco Sci; 1980 Apr; 35(4):253-62. PubMed ID: 6450060
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structural basis of muscarinic acetylcholine receptor subtype diversity.
    Peralta EG; Winslow JW; Ashkenazi A; Smith DH; Ramachandran J; Capon DJ
    Trends Pharmacol Sci; 1988 Feb; Suppl():6-11. PubMed ID: 3074539
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.